Control Bionics Ltd
ASX:CBL
Control Bionics Ltd
Revenue
Control Bionics Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Control Bionics Ltd
ASX:CBL
|
Revenue
AU$5.9m
|
CAGR 3-Years
21%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
Neurotech International Ltd
ASX:NTI
|
Revenue
AU$1.3m
|
CAGR 3-Years
148%
|
CAGR 5-Years
83%
|
CAGR 10-Years
N/A
|
|
ImpediMed Ltd
ASX:IPD
|
Revenue
AU$10.5m
|
CAGR 3-Years
17%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Revenue
AU$27.8m
|
CAGR 3-Years
24%
|
CAGR 5-Years
16%
|
CAGR 10-Years
9%
|
Cochlear Ltd
ASX:COH
|
Revenue
AU$2.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Revenue
AU$7.1m
|
CAGR 3-Years
93%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
See Also
What is Control Bionics Ltd's Revenue?
Revenue
5.9m
AUD
Based on the financial report for Jun 30, 2023, Control Bionics Ltd's Revenue amounts to 5.9m AUD.
What is Control Bionics Ltd's Revenue growth rate?
Revenue CAGR 5Y
46%
Over the last year, the Revenue growth was 25%. The average annual Revenue growth rates for Control Bionics Ltd have been 21% over the past three years , 46% over the past five years .